Mirae Asset Global ETFs Holdings’s Oramed Pharmaceuticals ORMP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.4K	Buy	+15,671	New	+$62.4K	﹤0.01%	2940

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ORMP Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 15,671 shares worth $75.4K. The stake represents ﹤0.01% of the portfolio and ranks #2940 among its holdings.

84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

Mirae Asset Global ETFs Holdings held 15,671 shares of Oramed Pharmaceuticals worth $75.4K as of Q2 2026.
Oramed Pharmaceuticals was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2940 holding.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.